High Efficacy And Safety Of The Combination Hcv Regimen Elbasvir And Grazoprevir For 8 Weeks In Treatment-Naive Non-Severe Fibrosis Hcvgt1b-Infected Patients: Final Results Of The Streager Study

JOURNAL OF HEPATOLOGY(2019)

引用 5|浏览37
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要